医学
冲程(发动机)
炎症
内科学
缺血性中风
重症监护医学
风险因素
疾病
作者
Peter J. Kelly,Robin Lemmens,Georgios Tsivgoulis
出处
期刊:Stroke
[Ovid Technologies (Wolters Kluwer)]
日期:2021-06-24
卷期号:52 (8): 2697-2706
被引量:6
标识
DOI:10.1161/strokeaha.121.034388
摘要
New therapeutic approaches are required for secondary prevention of residual vascular risk after stroke. Diverse sources of evidence support a causal role for inflammation in the pathogenesis of stroke. Randomized controlled trials of anti-inflammatory agents have reported benefit for secondary prevention in patients with coronary disease. We review the data from observational studies supporting a role for inflammation in pathogenesis of stroke, overview randomized controlled trials of anti-inflammatory therapy in cardiac disease and discuss the potential implications for stroke prevention therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI